.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Cipla
Deloitte
McKesson
Express Scripts
Dow
Farmers Insurance
Fish and Richardson
Covington
Fuji

Generated: September 21, 2017

DrugPatentWatch Database Preview

FLUVASTATIN SODIUM Drug Profile

« Back to Dashboard

Which patents cover Fluvastatin Sodium, and when can generic versions of Fluvastatin Sodium launch?

Fluvastatin Sodium is a drug marketed by Teva Pharms, Teva Pharms Usa, and Mylan Pharms Inc. and is included in four NDAs.

The generic ingredient in FLUVASTATIN SODIUM is fluvastatin sodium. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the fluvastatin sodium profile page.

Summary for Tradename: FLUVASTATIN SODIUM

Patents:0
Applicants:3
NDAs:4
Suppliers / Packagers: see list3
Bulk Api Vendors: see list81
Clinical Trials: see list2,428
Patent Applications: see list2,885
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLUVASTATIN SODIUM at DailyMed

Pharmacology for Tradename: FLUVASTATIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms
FLUVASTATIN SODIUM
fluvastatin sodium
CAPSULE;ORAL078407-001Jun 12, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
FLUVASTATIN SODIUM
fluvastatin sodium
TABLET, EXTENDED RELEASE;ORAL202458-001Sep 11, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
FLUVASTATIN SODIUM
fluvastatin sodium
CAPSULE;ORAL078407-002Jun 12, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
FLUVASTATIN SODIUM
fluvastatin sodium
TABLET, EXTENDED RELEASE;ORAL079011-001Jan 27, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
FLUVASTATIN SODIUM
fluvastatin sodium
CAPSULE;ORAL090595-002Apr 11, 2012ABRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
FLUVASTATIN SODIUM
fluvastatin sodium
CAPSULE;ORAL090595-001Apr 11, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Chubb
Deloitte
QuintilesIMS
Chinese Patent Office
Citi
Baxter
Boehringer Ingelheim
Mallinckrodt
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot